Neurogenic bladder dysfunction

Current Opinion in Urology

Volumn 9, Issue 4, 1999, Pages 303-307

  Madersbacher, Helmut G ^a,b  

^a Universitat Klinlken   (Austria)

^b Universität Klinlken   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; COLLAGEN; OXYBUTYNIN; PROPIVERINE; SPASMOLYTIC AGENT; TOLTERODINE; TROSPIUM CHLORIDE;

COGNITIVE DEFECT; DETRUSOR MUSCLE; DORSAL ROOT; ELECTROSTIMULATION THERAPY; GASTROINTESTINAL TRACT; HUMAN; HYPERREFLEXIA; INTRATHECAL DRUG ADMINISTRATION; MUSCLE RESECTION; NEUROGENIC BLADDER; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PARAPLEGIA; PATHOLOGICAL REFLEX; PRIORITY JOURNAL; QUADRIPLEGIA; REVIEW; RHIZOTOMY; SACRUM; SIDE EFFECT; SPHINCTER; SPINAL CORD LESION; URODYNAMICS; XEROSTOMIA;

HUMANS; MUSCLE, SMOOTH; PROGNOSIS; REFLEX; SPINAL CORD INJURIES; URINARY BLADDER, NEUROGENIC; URODYNAMICS;

EID: 0032778449     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199907000-00005     Document Type: Review

References (33)

1. Goldstein I, Siroky MB, Sax DS, Krane RJ. Neurourologic abnormalities in multiple sclerosis. J Urol 1982; 128:541-545.
2. Koldewijn EL, Hommes OR, Lemmens WAJG, et al. Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J Urol 1995; 154:169-173.
3. Kim YH, Goodman CH, Omessi E, Rivera V, Kattan MW, Boon TB. The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis. J Urol 1998; 159:972-976.
4. Giannantoni A, Scivoletto G, di Stasi SM, Grasso MG, Vespasiani G, Castellano V. Urological dysfunction and upper urinary tract involvement in multiple sclerosis patients. Neurourol Urodynam 1998; 17:89-98.
5. Barbalias GA, Nikiforidis G, Liatsikos EN. Vesicourethral dysfunction associated with multiple sclerosis: clinical and urodynamic perspectives. J Urol 1998; 160:106-111. The results clearly show that in multiple sclerosis-patients urodynamics are essential to identify risk factors and to prevent complications, which may deteriorate the urinary tract and the patient's quality of life.
6. Watanabe T, Vaccaro AR, Kumon H, Welch WC, Rivas DA, Chancellor MB. High incidence of occult neurogenic bladder dysfunction in neurologically intact patients with thoracolumbar spinal injuries. J Urol 1998; 159:965-968. 40% of patients with a thoraco-lumbar spine injury, even if otherwise neurologically intact, suffer from neurogenic LUT-dysfunction, which can only be identified by urodynamics.
7. Shenot PJ, Rivas DA, Watanabe T, Chancellor MB. Early predictors of bladder recovery and urodynamics after spinal cord injury. Neurourol Urodynam 1998; 17:25-29.
8. Kim YH, Kattan MW, Boon TB. Bladder leak point pressure: the measure for sphincterotomy success in spinal cord injured patients with external detrusor sphincter dyssynergia. J Urol 1998; 159:493-497.
9. Palmer LS, Richards I, Kaplan WE. Subclinical changes in bladder function in children presenting with nonurological symptoms of the tethered cord syndrome. J Urol 1998; 159:231-234. In children with a tethered cord syndrome, even if clinically asymptomatic in regards to bladder and sphincter function, in the majority urodynamics reveal a neurogenetic UT-dysfunction, which may either merit a management change or may serve as another marker for the success of untethering.
10. Buffa P, di Rovasenda E, Scarsi PL, Granata C, Podesta E, Ciardi MR, Cama A. Vesico sphincteric function in spinal lipomas. Eur J Pediatr Surg 1997; 7 (suppl 1):59-60.
11. Lewis MA, Shaw J, Sattar TM, Bannister CM. The spectrum of spinal cord dysraphism and bladder neuropathy in children. Eur J Pediatr Surg 1997; 7 (suppl 1):35-37.
12. Kurzrock EA, Polse S. Renal deterioration in myelodysplastic children: urodynamic evaluation and clinical correlates. J Urol 1998; 159:1657-1661.
13. Abrams P, Freeman R, Anderström C, Mattiasson A. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol 1998; 81:801-810.
14. Van Kerrebroeck PEVA, Amarenco G, Thüroff JW, Madersbacher HG, Lock MTWT, Messelink EJ, Soler JM. Dose-ranging study of tolterodine in patients with detrusor hyperreflexia. Neurourol Urodynam 1998; 17:499-512.
15. Donnellan CA, Fook L, McDonald P, Playfer JR. Oxybutynin and cognitive dysfunction. BMJ 1997; 315:1363-1364.
16. n) in patients with motor urge syndrome (detrusor instability): a double-blind, randomised, multicentre, placebo-controlled study. J Clin Res 1998; 1:439-451.
17. Stöhrer M, Madersbacher H, Richter R, Wehnert J, Dreikorn K. Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia-a double-blind, placebo-controlled clinical trial. Spinal Cord 1999; 37:196-200.
18. Amark P, Eksborg S, Juneskans O, Bussman G, Palm C. Phamacokinetics and effects of intravesical oxybutynin on the paediatric neurogenic bladder. Br J Urol 1998; 82:859-864.
19. Wiart L, Joseph PA, Petit H, Dosque JP, de Sèze, Brochet B, Deminiere C, et al. The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results. Spinal Cord 1998; 36:95-99.
20. de Sèze M, Wiart L, Joseph PA, Dosque JP, Mazaux JM, Barat M. Capsaicin and neurogenic detrusor hyperreflexia: a double blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodynam 1998; 17:513-523.
21. Denys P, Chartier-Kastler E, Azouvi P, Remy-neris O, Bussel B. Intrathecal clonidine for refractory detrusor hyperreflexia in spinal cord injured patients: a preliminary report. J Urol 1998; 160:2137-2138.
22. Ghoniem GM, Shoukry MS, Hassouna ME. Detrusor properties in myelomeningocele patients: in vitro study. J Urol 1998; 159:2193-2196.
23. Yokota T, Yamaguchi O, Shishido K, Shiraiwa Y. Changes in cholinergic and purinergic neurotransmission in pathologic bladder of chronic spinal rabbit. Neurourol Urodynam 1994, 13:466-467.
24. Ebner A, Jiang C, Lindstroem S. Intravesical electrical stimulation - an experimental analysis of the mechanism of action. J Urol 1992; 118:920-924.
25. Madersbacher H. Intravesical electrical stimulation for the rehabilitation of the neuropathic bladder. Paraplegia 1990; 28:349-353.
26. Marshal DF, Boston VE, Altered bladder and bowel function following cutaneous electrical field stimulation in children with spina bifida - interim results of a randomized double-blind placebo-controlled trial. Eur J Pediatr Surg 1997; 7:41-43.
27. Ishigooka M, Suzuki Y, Hashimoto T, Sasagawa I, Nakada T, Handa Y. A new technique for sacral nerve stimulation: a percutaneous method for urinary incontinence caused by spinal cord injury. Br J Urol 1998; 81:315-318.
28. Skobejko-Wlodarska L, Strulak K, Nachulewicz P, Szymkiewicz C. Bladder augmentation in myelodysplastic children. Br J Urol 1998; 81:114-116.
29. Stöhrer M, Goepel M, Kramer G, Löchner-Ernst D, Rübben H. Die Detrusormyekotomie (Autoaugmentation) in der Behandlung der hyperreflexiven Low-compliance-Blase. Der Urologen [A] 1999; 38:30-37.
30. Schurch B, Knapp PA, Jeanmonod D, Rodic B, Rossier AB. Does sacral posterior rhizotomy suppress autonomic hyperreflexia in patients with spinal cord injury? Br J Urol 1998; 81:73-82.
31. Silveri M, Capitanucci ML, Mosiello G, Broggi G, de Gennaro M. Endoscopic treatment for urinary incontinence in children with a congenital neuropathic bladder. Br J Urol 1998; 82:694-697.
32. Kohn U, Balsara RK, Rabinovitch H. Placement of a bladder neck purse-string cuff for a management of incontinence in children with myelodysplasia. Urology 1998; 51:1027-1030.
33. de Groat WC. A neurologic base for the overactive bladder. Urology 1997; 50:36-52.